Advertisement

Cellular and Molecular Neurobiology

, Volume 31, Issue 3, pp 377–391 | Cite as

Neuroprotective Changes of Striatal Degeneration-Related Gene Expression by Acupuncture in an MPTP Mouse Model of Parkinsonism: Microarray Analysis

  • Yeong-Gon Choi
  • Sujung Yeo
  • Yeon-Mi Hong
  • Sabina Lim
Original Research

Abstract

Acupuncture at acupoints GB34 and LR3 has been reported to inhibit nigrostriatal degeneration in Parkinsonism models, yet the genes related to this preventive effect of acupuncture on the nigrostriatal dopaminergic system remain elusive. This study investigated gene expression profile changes in the striatal region of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism models after acupuncture at the acupoints GB34 and LR3 using a whole transcript genechip microarray (Affymetrix genechip mouse gene 1.0 ST array). It was confirmed that acupuncture at these acupoints could inhibit the decrease of tyrosine hydroxylase and dopamine transporter in the nigrostriatal region of the MPTP model while acupuncture at the non-acupoints could not counteract this decrease. Genechip gene array analysis (fold change cutoff 1.3 and P < 0.05) showed that 12 of the 69 probes up-regulated in MPTP when compared to the control were down-regulated by acupuncture at the acupoints. Of these 12 probes, 11 probes (nine annotated genes) were exclusively down-regulated by acupuncture only at the acupoints; the Gfral gene was excluded because it was commonly down-regulated by acupuncture at both the acupoints and the non-acupoints. In addition, 28 of the 189 probes down-regulated in MPTP when compared to the control were up-regulated by acupuncture at the acupoints. Of these 28 probes, 19 probes (seven annotated genes) were exclusively up-regulated by acupuncture only at the acupoints while nine probes were commonly up-regulated by acupuncture at both the acupoints and the non-acupoints. The regulation patterns of representative genes in real-time RT-PCR correlated with those of the genes in the microarray. These results suggest that the 30 probes (16 annotated genes), which are affected by MPTP and acupuncture only at the acupoints, are responsible for exerting in the striatal regions the inhibitory effect of acupuncture at the acupoints on MPTP-induced striatal degeneration.

Keywords

Parkinson’s disease Gene array Differentially expressed genes Striatum Neurodegeneration 

Notes

Acknowledgments

This work was supported by the Mid-career Researcher Program through an NRF grant funded by the MEST, Republic of Korea (No. 2010-0000385).

Supplementary material

10571_2010_9629_MOESM1_ESM.tif (353 kb)
Supplementary material 1 (TIFF 353 kb)
10571_2010_9629_MOESM2_ESM.xls (16 kb)
Supplementary material 2 (XLS 16 kb)
10571_2010_9629_MOESM3_ESM.xls (182 kb)
Supplementary material 3 (XLS 182 kb)
10571_2010_9629_MOESM4_ESM.xls (380 kb)
Supplementary material 4 (XLS 380 kb)

References

  1. Aicardi J (1994) The place of neuronal migration abnormalities in child neurology. Can J Neurol Sci 21:185–193PubMedGoogle Scholar
  2. Airaksinen MS, Meyer M (1996) Most classes of dorsal root ganglion neurons are severely depleted but not absent in mice lacking neurotrophin-3. Neuroscience 73:907–911CrossRefPubMedGoogle Scholar
  3. An JH, Lee SY, Jeon JY, Cho KG, Kim SU, Lee MA (2009) Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 8:2873–2881CrossRefPubMedGoogle Scholar
  4. Bezard E, Dovero S, Bioulac B, Gross C (1997) Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp Neurol 148:288–292CrossRefPubMedGoogle Scholar
  5. Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133:1747–1754CrossRefPubMedGoogle Scholar
  6. Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, Rousseau R, Combaret V, Bénard J, Tauszig-Delamasure S, Mehlen P (2010) Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest 120:850–858CrossRefPubMedGoogle Scholar
  7. Braun A, Breuss M, Salzer MC, Flint J, Cowan NJ, Keays DA (2010) Tuba8 is expressed at low levels in the developing mouse and human brain. Am J Hum Genet 86:819–822CrossRefPubMedGoogle Scholar
  8. Burmester T, Weich B, Reinhardt S, Hankeln T (2000) A vertebrate globin expressed in the brain. Nature 407:520–523CrossRefPubMedGoogle Scholar
  9. Cepeda C, Walsh JP, Peacock W, Buchwald NA, Levine MS (1993) Dye-coupling in human neocortical tissue resected from children with intractable epilepsy. Cereb Cortex 3:95–107CrossRefPubMedGoogle Scholar
  10. Chen Y, Riley DJ, Chen PL, Lee WH (1997) HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol 17:6049–6056PubMedGoogle Scholar
  11. Chen HH, Tourtellotte WG, Frank E (2002) Muscle spindle-derived neurotrophin 3 regulates synaptic connectivity between muscle sensory and motor neurons. J Neurosci 22:3512–3519PubMedGoogle Scholar
  12. Choi YG, Lim S (2010) Nε-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie 92:1379–1386CrossRefPubMedGoogle Scholar
  13. Choi YG, Park JH, Lim S (2009) Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced Parkinsonism model. Neurosci Lett 450:92–96CrossRefPubMedGoogle Scholar
  14. Cina C, Bechberger JF, Ozog MA, Naus CC (2007) Expression of connexins in embryonic mouse neocortical development. J Comp Neurol 504:298–313CrossRefPubMedGoogle Scholar
  15. Dai YS, Xu J, Molkentin JD (2005) The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol Cell Biol 25:9936–9948CrossRefPubMedGoogle Scholar
  16. Diaz-Rodríguez E, Sotillo R, Schvartzman JM, Benezra R (2008) Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci USA 105:16719–16724CrossRefPubMedGoogle Scholar
  17. Emborg ME (2007) Nonhuman primate models of Parkinson’s disease. ILAR J 48:339–355PubMedGoogle Scholar
  18. Ernfors P, Van De Water T, Loring J, Jaenisch R (1995) Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14:1153–1164CrossRefPubMedGoogle Scholar
  19. Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D, Moens L, Dewilde S (2006) Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci Lett 410:146–151CrossRefPubMedGoogle Scholar
  20. Fornai F, Schlüter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Südhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413–3418CrossRefPubMedGoogle Scholar
  21. Genç B, Ozdinler PH, Mendoza AE, Erzurumlu RS (2004) A chemoattractant role for NT-3 in proprioceptive axon guidance. PLoS Biol 2:e403CrossRefPubMedGoogle Scholar
  22. Guerrini R, Filippi T (2005) Neuronal migration disorders, genetics, and epileptogenesis. J Child Neurol 20:287–299CrossRefPubMedGoogle Scholar
  23. Guo Y, Martinez-Williams C, Rannels DE (2003) Gap junction-microtubule associations in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 285:L1213–L1221PubMedGoogle Scholar
  24. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol. 8:382–397CrossRefPubMedGoogle Scholar
  25. Hong MS, Park HK, Yang JS, Park HJ, Kim ST, Kim SN, Park JY, Song JY, Park HK, Jo DJ, Park SW, HwanYun D, Ban JY, Chung JH (2010) Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease model. Neurol Res 32:74–78CrossRefPubMedGoogle Scholar
  26. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E (2000) α-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401–410CrossRefPubMedGoogle Scholar
  27. Hwang SH, Choi YG, Jeong MY, Hong YM, Lee JH, Lim S (2009) Microarray analysis of gene expression profile by treatment of Cinnamomi ramulus in lipopolysaccharide-stimulated BV-2 cells. Gene 443:83–90CrossRefPubMedGoogle Scholar
  28. Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, Lim S (2007) Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res 1131:211–219CrossRefPubMedGoogle Scholar
  29. Khan AA, Mao XO, Banwait S, Jin K, Greenberg DA (2007a) Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc Natl Acad Sci USA 104:19114–19119CrossRefPubMedGoogle Scholar
  30. Khan AA, Sun Y, Jin K, Mao XO, Chen S, Ellerby LM, Greenberg DA (2007b) A neuroglobin-overexpressing transgenic mouse. Gene 398:172–176CrossRefPubMedGoogle Scholar
  31. Li TY, Colley D, Barr KJ, Yee SP, Kidder GM (2007) Rescue of oogenesis in Cx37-null mutant mice by oocyte-specific replacement with Cx43. J Cell Sci 120:4117–4125CrossRefPubMedGoogle Scholar
  32. Li RC, Pouranfar F, Lee SK, Morris MW, Wang Y, Gozal D (2008) Neuroglobin protects PC12 cells against beta-amyloid-induced cell injury. Neurobiol Aging 29:1815–1822CrossRefPubMedGoogle Scholar
  33. Lin HQ, Choi R, Chan KL, Ip D, Tsim KW, Wan DC (2010) Differential gene expression profiling on the muscle of acetylcholinesterase knockout mice: a preliminary analysis. Chem-Biol Interact 187:120–123CrossRefPubMedGoogle Scholar
  34. Mandel S, Weinreb O, Youdim MB (2003) Using cDNA microarray to assess Parkinson’s disease models and the effects of neuroprotective drugs. Trends Pharmacol Sci 24:184–191CrossRefPubMedGoogle Scholar
  35. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB (2005) Gene expression profiling of sporadic Parkinson’s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann NY Acad Sci 1053:356–375CrossRefPubMedGoogle Scholar
  36. Maness LM, Kastin AJ, Weber JT, Banks WA, Beckman BS, Zadina JE (1994) The neurotrophins and their receptors: structure, function, and neuropathology. Neurosci Biobehav Rev 18:143–159CrossRefPubMedGoogle Scholar
  37. Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC Jr, Lau YS (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson’s disease. Brain Res 956:156–165CrossRefPubMedGoogle Scholar
  38. Miller RM, Federoff HJ (2005) Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems. Neuroscientist 11:539–549CrossRefPubMedGoogle Scholar
  39. Miller RM, Callahan LM, Casaceli C, Chen L, Kiser GL, Chui B, Kaysser-Kranich TM, Sendera TJ, Palaniappan C, Federoff HJ (2004) Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci 24:7445–7454CrossRefPubMedGoogle Scholar
  40. Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, Federoff HJ (2006) Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson’s disease. Neurobiol Dis 21:305–313CrossRefPubMedGoogle Scholar
  41. Miwa T, Watanabe A, Mitsumoto Y, Furukawa M, Fukushima N, Moriizumi T (2004) Olfactory impairment and Parkinson’s disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Otolaryngol Suppl 553:80–84CrossRefPubMedGoogle Scholar
  42. Morissette M, Goulet M, Grondin R, Blanchet P, Bédard PJ, Di Paolo T, Lévesque D (1998) Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Eur J Neurosci 10:2565–2573CrossRefPubMedGoogle Scholar
  43. Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK (2008) Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo. Neuroscience 154:606–620CrossRefPubMedGoogle Scholar
  44. Neesen J, Hartwich T, Brandhorst G, Aumüller G, Gläser B, Burfeind P, Mendoza-Lujambio I (2002) Tep22, a novel testicular expressed gene, is involved in the biogenesis of the acrosome and the midpiece of the sperm tail. Biochem Biophys Res Commun 297:737–748CrossRefPubMedGoogle Scholar
  45. Otto D, Unsicker K (1994) FGF-2 in the MPTP model of Parkinson’s disease: effects on astroglial cells. Glia 11:47–56CrossRefPubMedGoogle Scholar
  46. Pardridge WM (2005) Tyrosine hydroxylase replacement in experimental Parkinson’s disease with transvascular gene therapy. NeuroRx 2:129–138CrossRefPubMedGoogle Scholar
  47. Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH (2003) Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson’s disease model. Exp Neurol 180:93–98CrossRefPubMedGoogle Scholar
  48. Pattarini R, Rong Y, Qu C, Morgan JI (2008) Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum. Neuroscience 155:1174–1194CrossRefPubMedGoogle Scholar
  49. Peinado A, Yuste R, Katz LC (1993) Extensive dye coupling between rat neocortical neurons during the period of circuit formation. Neuron 10:103–114CrossRefPubMedGoogle Scholar
  50. Pettingill LN, Minter RL, Shepherd RK (2008) Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 152:821–828CrossRefPubMedGoogle Scholar
  51. Pilkinton M, Sandoval R, Song J, Ness SA, Colamonici OR (2007) Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1. J Biol Chem 282:168–175CrossRefPubMedGoogle Scholar
  52. Pirkevi C, Lesage S, Brice A, Başak AN (2009) From genes to proteins in mendelian Parkinson’s disease: an overview. Anat Rec (Hoboken) 292:1893–1901Google Scholar
  53. Reynard LN, Cocquet J, Burgoyne PS (2009) The multi-copy mouse gene Sycp3-like Y-linked (Sly) encodes an abundant spermatid protein that interacts with a histone acetyltransferase and an acrosomal protein. Biol Reprod 81:250–257CrossRefPubMedGoogle Scholar
  54. Rufer M, Wirth SB, Hofer A, Dermietzel R, Pastor A, Kettenmann H, Unsicker K (1996) Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated Parkinsonian mice. J Neurosci Res 46:606–617CrossRefPubMedGoogle Scholar
  55. Russo MA, Giustizieri ML, Favale A, Fantini MC, Campagnolo L, Konda D, Germano F, Farini D, Manna C, Siracusa G (1999) Spatiotemporal patterns of expression of neurotrophins and neurotrophin receptors in mice suggest functional roles in testicular and epididymal morphogenesis. Biol Reprod 61:1123–1132CrossRefPubMedGoogle Scholar
  56. Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta AR (2009) Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson’s disease. Neurotox Res 16:127–139CrossRefPubMedGoogle Scholar
  57. Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661–1668CrossRefPubMedGoogle Scholar
  58. Simon AM, Goodenough DA (1998) Diverse functions of vertebrate gap junctions. Trends Cell Biol 8:477–483CrossRefPubMedGoogle Scholar
  59. Simon AM, McWhorter AR (2002) Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251:206–220CrossRefPubMedGoogle Scholar
  60. Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens RM, Benes FM, Sonntag KC (2009) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson’s disease pathology. Brain 132:1795–1809CrossRefPubMedGoogle Scholar
  61. Stanchi F, Corso V, Scannapieco P, Ievolella C, Negrisolo E, Tiso N, Lanfranchi G, Valle G (2000) TUBA8: a new tissue-specific isoform of alpha-tubulin that is highly conserved in human and mouse. Biochem Biophys Res Commun 270:1111–1118CrossRefPubMedGoogle Scholar
  62. Sun Y, Jin K, Mao XO, Xie L, Peel A, Childs JT, Logvinova A, Wang X, Greenberg DA (2005) Effect of aging on neuroglobin expression in rodent brain. Neurobiol Aging 26:275–278CrossRefPubMedGoogle Scholar
  63. Tessier CR, Doyle GA, Clark BA, Pitot HC, Ross J (2004) Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res 64:209–214CrossRefPubMedGoogle Scholar
  64. Watson ED, Mattar P, Schuurmans C, Cross JC (2009) Neural stem cell self-renewal requires the Mrj co-chaperone. Dev Dyn 238:2564–2574CrossRefPubMedGoogle Scholar
  65. Weinlich S, Hüttelmaier S, Schierhorn A, Behrens SE, Ostareck-Lederer A, Ostareck DH (2009) IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3′UTR. RNA 15:1528–1542CrossRefPubMedGoogle Scholar
  66. Westerlund M, Hoffer B, Olson L (2010) Parkinson’s disease: exit toxins, enter genetics. Prog Neurobiol 90:146–156CrossRefPubMedGoogle Scholar
  67. Wigge PA, Kilmartin JV (2001) The Ndc80p complex from Saccharomyces cerevisiae contains conserved centromere components and has a function in chromosome segregation. J Cell Biol 152:349–360CrossRefPubMedGoogle Scholar
  68. Wirth SB, Rufer M, Unsicker K (1996) Early effects of FGF-2 on glial cells in the MPTP-lesioned striatum. Exp Neurol 137:191–200CrossRefPubMedGoogle Scholar
  69. Yano H, Torkin R, Martin LA, Chao MV, Teng KK (2009) Proneurotrophin-3 is a neuronal apoptotic ligand: evidence for retrograde-directed cell killing. J Neurosci 29:14790–14802CrossRefPubMedGoogle Scholar
  70. Young JM, Shykind BM, Lane RP, Tonnes-Priddy L, Ross JA, Walker M, Williams EM, Trask BJ (2003) Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels. Genome Biol 4:R71CrossRefPubMedGoogle Scholar
  71. Zhu W, Giangrande PH, Nevins JR (2004) E2Fs link the control of G1/S and G2/M transcription. EMBO J 23:4615–4626CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Yeong-Gon Choi
    • 1
  • Sujung Yeo
    • 1
    • 2
  • Yeon-Mi Hong
    • 1
    • 2
  • Sabina Lim
    • 1
    • 2
  1. 1.Research Group of Pain and Neuroscience, WHO Collaborating Center for Traditional Medicine, East–West Medical Research InstituteKyung Hee UniversitySeoulRepublic of Korea
  2. 2.Department of Basic Eastern Medical ScienceKyung Hee UniversitySeoulRepublic of Korea

Personalised recommendations